MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P- glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1) (vol 35, 25, 2016)

被引：0
|
作者：
Zhao, Lin [1 ]
Wang, Yan [1 ]
Jiang, Longyang [1 ]
He, Miao [1 ]
Bai, Xuefeng [1 ]
Yu, Lifeng [1 ]
Wei, Minjie [1 ]
机构：
[1] China Med Univ, Sch Pharm, Dept Pharmacol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China
来源：
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 2022年 / 41卷 / 01期
关键词：
D O I：
10.1186/s13046-022-02312-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 3 条
  • [1] MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
    Lin Zhao
    Yan Wang
    Longyang Jiang
    Miao He
    Xuefeng Bai
    Lifeng Yu
    Minjie Wei
    Journal of Experimental & Clinical Cancer Research, 35
  • [2] MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
    Zhao, Lin
    Wang, Yan
    Jiang, Longyang
    He, Miao
    Bai, Xuefeng
    Yu, Lifeng
    Wei, Minjie
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2016, 35
  • [3] Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1)
    Lin Zhao
    Yan Wang
    Longyang Jiang
    Miao He
    Xuefeng Bai
    Lifeng Yu
    Minjie Wei
    Journal of Experimental & Clinical Cancer Research, 41
1